Dr. Melissa A. Burgess
Overview
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma.
Dr. Burgess is rated as an Elite provider by MediFind in the treatment of Chondrosarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 27 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 1 clinical trial in the study of Chondrosarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Additional Areas of Focus
Dr. Burgess has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
26 Clinical Trials
David Friedland is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Friedland is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Bone Marrow Aspiration.
UPMC Hillman Cancer Center
Kiran Kumar Rajasenan, MD, is a medical oncologist at UPMC Hillman Cancer Center, Wexford. Board-certified in internal medicine and medical oncology, Dr. Rajasenan received his medical degree from Hahnemann Medical College, now Drexel University College of Medicine in Philadelphia. He completed his residency at Allegheny General Hospital in Pittsburgh. Dr. Rajasenan is rated as an Advanced provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Non-Hodgkin Lymphoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma.
UPMC Hillman Cancer Center
Daniel P. Petro, MD, is a medical oncologist and hematologist at Hillman Cancer Center. He treats all cancer types, and has a special interest in a multidisciplinary approach to thoracic malignancies. Dr. Petro is also heavily involved in the research of Phase I trials. Dr. Petro is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Awake Craniotomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adult Soft Tissue SarcomaDr. Burgess isElite. Learn about Adult Soft Tissue Sarcoma.
- ChondrosarcomaDr. Burgess isElite. Learn about Chondrosarcoma.
- LiposarcomaDr. Burgess isElite. Learn about Liposarcoma.
- Merkel Cell CarcinomaDr. Burgess isElite. Learn about Merkel Cell Carcinoma.
- Synovial SarcomaDr. Burgess isElite. Learn about Synovial Sarcoma.
- Distinguished
- Alveolar Soft Part SarcomaDr. Burgess isDistinguished. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Burgess isDistinguished. Learn about Angiosarcoma.
- Bone TumorDr. Burgess isDistinguished. Learn about Bone Tumor.
- Desmoplastic Small Round Cell TumorDr. Burgess isDistinguished. Learn about Desmoplastic Small Round Cell Tumor.
- Epithelioid SarcomaDr. Burgess isDistinguished. Learn about Epithelioid Sarcoma.
- Ewing SarcomaDr. Burgess isDistinguished. Learn about Ewing Sarcoma.
- Advanced
- Angiosarcoma of the LiverDr. Burgess isAdvanced. Learn about Angiosarcoma of the Liver.
- Angiosarcoma of the ScalpDr. Burgess isAdvanced. Learn about Angiosarcoma of the Scalp.
- AstrocytomaDr. Burgess isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- ChordomaDr. Burgess isAdvanced. Learn about Chordoma.
- Desmoid TumorDr. Burgess isAdvanced. Learn about Desmoid Tumor.
- Experienced
- Adenoid Cystic CarcinomaDr. Burgess isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Burgess isExperienced. Learn about Adrenal Cancer.
- AgranulocytosisDr. Burgess isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Burgess isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Basal Cell Skin CancerDr. Burgess isExperienced. Learn about Basal Cell Skin Cancer.
- Brain Stem CancerDr. Burgess isExperienced. Learn about Brain Stem Cancer.